InvestorsHub Logo
icon url

joshalex5

04/06/16 5:34 PM

#58422 RE: apostrophe #58421

Every company has she has authorized any company could reissue new shares. Like you said they did not look at the science or thus could help alzhiemers patients. The drug has little side affects. Anyone could write about what he wrote about write about the science because that's technical and most guys don't have the technical experience. He knows nothing of science. I enjoyed what you wrote.
icon url

powerwalker

04/06/16 6:10 PM

#58423 RE: apostrophe #58421

A great summary, apostrophe, thank you for your analysis.

But given your name, the correct spelling is "its" and not "it's" which is used as the contraction for "it is."

Don't feel bad, though, as it took Microsoft two decades to get "its" software to spell "its" correctly. ;)
icon url

DOLPHY

04/06/16 6:52 PM

#58425 RE: apostrophe #58421

It worries me that the analysis of the 12 weeks data is taking so long with it involving so few patients. I spoke to IR two weeks ago and was told that the data is being analysed. I suspect that the results were marginal and they are trying to put a positive look on them. The extension would point in a different direction but I think that my suspiction is correct.